Status: Recruiting
Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants
A phase 2 randomised, three-arm, parallel-group, dose-ranging trial to determine safety, efficacy and optimal dosing of intravenous anakinra in premature neonates, with subcutaneous pharmacokinetic sub-study.
Participants needed: 24
Trial details
Phase: Phase 2Age: 24-29Biological sex: AllType: InterventionalSponsor: Monash Medical CentreUpdated: Nov 28, 2025Locations: 2
Eligibility criteria
Born between 24+0 and 28+6 weeks of gestation
Inability of the legal representatives to consent, [+8]